藥碼
CEF08
藥名
Cefoxitin (sod) 2 g/Vial
英文商品名
CefMORE 針 2 g
中文商品名
世優注射劑
螢幕名
Cefmore 針 2 g/Vial
劑型
Inj
規格
成分
藥理分類
Cephalosporins
健保碼
AB38843212
ATC碼
藥品圖片
外觀圖片
適應症
Cephalosporins類抗生素 (二代)

Bacteremia/sepsis: caused by Streptococcus pneumoniae, Staphylococcus aureus, Escherichia coli, Klebsiella species, and Bacteroides species including B. fragilis
Bone and joint infections: caused by S. aureus
Gynecological infections: caused by E. coli, Neisseria gonorrhoeae, Bacteroides species including Bacteroides fragilis, Clostridium species, P. niger, Peptostreptococcus species, and Streptococcus agalactiae
Lower respiratory tract infections: Treatment of pneumonia and lung abscess, caused by S. pneumoniae, other streptococci, S. aureus, E. coli, Klebsiella species, Haemophilus influenzae, and Bacteroides species
Septicemia: caused by S. pneumoniae, S. aureus, E. coli, Klebsiella species, and Bacteroides species
Skin and skin structure infections: caused by S. aureus, Staphylococcus epidermidis, Streptococcus pyogenes and other streptococci, E. coli, Proteus mirabilis, Klebsiella species, Bacteroides species including B. fragilis, Clostridium species, P. niger, and Peptostreptococcus species
Urinary tract infections: Treatment of UTIs caused by E. coli, Klebsiella species, P. mirabilis, Morganella morganii, Proteus vulgaris, and Providencia species
藥理
Antibiotic, Cephalosporin
藥動學
Absorption:
Bioavailability, rectal: Increases to 17% with sodium octanoate or sodium salicylate
Distribution:
1. Protein binding: 41% to 75%
2. Vd, obese adults: 18.9 L
3. Dialyzable: Yes (hemodialysis), 86%
Metabolism:
1. Hepatic: Less than 2%
2. Descarbamyl metabolite: Inactive
Excretion:
1. Bile: Less than 1%
2. Renal: 85% unchanged; Renal clearance: 299 mL/minute
3. Total body clearance, obese adults: 14.7 L/hr
Elimination Half Life:
41 to 59 minutes
禁忌症
Hypersensitivity reactions to cefoxitin or other cephalosporin antibiotics should not receive the drug.
懷孕分類
B (FDA)
哺乳分類
Infant risk is minimal
副作用
Common: thrombophlebitis, diarrhea
Serious: Erythema multiforme, Stevens-Johnson syndrome, Pseudomembranous enterocolitis, Anaphylaxis.
劑量和給藥方法
General: 1–2 g IV or IM Q6 - 8H
In severe infections: 2 g IV Q4H or 3 g IV Q6H
小兒調整劑量
(>3 months of age and Children) 80 to 160 mg/kg/day in 3 to 6 equally divided doses. Maximum daily dosage is 12 g.
腎功能調整劑量
1. ClCr 30-50 mL/min: Administer 1-2 g Q 8-12H
2. ClCr 10-29 mL/minute: Administer 1-2 g Q12-24H
3. ClCr 5-9 mL/minute: Administer 0.5-1 g Q12-24H
4. ClCr <5 mL/minute: Administer 0.5-1 g Q24-48H
肝功能調整劑量
安定性
藥袋資訊
臨床用途
抗生素
主要副作用
腹瀉、腸胃不適、胃痛等
泡製方法
儲存方式
請置於 15-30℃ 乾燥處儲存
注意事項
其他說明
藥局 b1 | 小庫 A3 | 藥庫 注C12
藥品外觀
顏色
形狀
剝痕
標記1
標記2
其他
健保藥價
113
自費價
150.29
仿單
資料庫
健保給付規定